OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute Ischemic Stroke
William J. Powers
New England Journal of Medicine (2020) Vol. 383, Iss. 3, pp. 252-260
Closed Access | Times Cited: 196

Showing 1-25 of 196 citing articles:

Cell Death Mechanisms in Cerebral Ischemia–Reperfusion Injury
Qian Zhang, Meng Jia, Yunfu Wang, et al.
Neurochemical Research (2022) Vol. 47, Iss. 12, pp. 3525-3542
Closed Access | Times Cited: 118

Ischemic stroke associated with COVID-19: a systematic review and meta-analysis
Wenzhang Luo, Xiang Liu, Kunyang Bao, et al.
Journal of Neurology (2021) Vol. 269, Iss. 4, pp. 1731-1740
Open Access | Times Cited: 111

Endoplasmic Reticulum Stress and the Unfolded Protein Response in Cerebral Ischemia/Reperfusion Injury
Lei Wang, Yan Liu, Xu Dong Zhang, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 74

Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies
Jun Liao, Li Fan, Yi Li, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 439-464
Closed Access | Times Cited: 56

Astrocytic LRP1 enables mitochondria transfer to neurons and mitigates brain ischemic stroke by suppressing ARF1 lactylation
Jian Zhou, Lifang Zhang, Jianhua Peng, et al.
Cell Metabolism (2024) Vol. 36, Iss. 9, pp. 2054-2068.e14
Closed Access | Times Cited: 41

Bioactive Ceria Nanoenzymes Target Mitochondria in Reperfusion Injury to Treat Ischemic Stroke
Jun Liao, Yi Li, Fan Li, et al.
ACS Nano (2024)
Closed Access | Times Cited: 39

A DNA Nanostructure-Based Neuroprotectant against Neuronal Apoptosis via Inhibiting Toll-like Receptor 2 Signaling Pathway in Acute Ischemic Stroke
Mi Zhou, Tianxu Zhang, Bowen Zhang, et al.
ACS Nano (2021) Vol. 16, Iss. 1, pp. 1456-1470
Closed Access | Times Cited: 97

Toll‐like receptors in neuroinflammation, neurodegeneration, and alcohol‐induced brain damage
María Pascual, Maria Calvo‐Rodriguez, Lucı́a Núñez, et al.
IUBMB Life (2021) Vol. 73, Iss. 7, pp. 900-915
Open Access | Times Cited: 75

Emerging role of PARP‐1 and PARthanatos in ischemic stroke
Shuiqiao Liu, Weibo Luo, Yingfei Wang
Journal of Neurochemistry (2021) Vol. 160, Iss. 1, pp. 74-87
Open Access | Times Cited: 70

Overview of Acute Ischemic Stroke Evaluation and Management
Tasneem F. Hasan, Hunaid Hasan, Roger E. Kelley
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1486-1486
Open Access | Times Cited: 58

Recent progress (2015–2020) in the investigation of the pharmacological effects and mechanisms of ginsenoside Rb1, a main active ingredient in Panax ginseng Meyer
Zuan Lin, Rongfang Xie, Chenhui Zhong, et al.
Journal of Ginseng Research (2021) Vol. 46, Iss. 1, pp. 39-53
Open Access | Times Cited: 55

Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy
Han Liu, Zhen Geng, Jiacan Su
Extracellular Vesicles and Circulating Nucleic Acids (2022) Vol. 3, Iss. 1, pp. 63-86
Open Access | Times Cited: 54

Targeted alleviation of ischemic stroke reperfusion via atorvastatin-ferritin Gd-layered double hydroxide
Li Wang, Baorui Zhang, Xueting Yang, et al.
Bioactive Materials (2022) Vol. 20, pp. 126-136
Open Access | Times Cited: 49

Neural Stem Cells Therapy for Ischemic Stroke: Progress and Challenges
Tong Zhao, Tongming Zhu, Liqian Xie, et al.
Translational Stroke Research (2022) Vol. 13, Iss. 5, pp. 665-675
Closed Access | Times Cited: 39

Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives
Fang-Ying Chiu, Yun Yen
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 34

Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities
Xiaoxue Xu, Bowen Sun, Chuansheng Zhao
Neurobiology of Disease (2023) Vol. 187, pp. 106314-106314
Open Access | Times Cited: 26

PLA2G2E-mediated lipid metabolism triggers brain-autonomous neural repair after ischemic stroke
Akari Nakamura, Seiichiro Sakai, Yoshitaka Taketomi, et al.
Neuron (2023) Vol. 111, Iss. 19, pp. 2995-3010.e9
Open Access | Times Cited: 25

Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke
Yang Liu, Lauren Guttman, Valina L. Dawson, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116174-116174
Closed Access | Times Cited: 12

Neutrophil extracellular traps mediated by platelet microvesicles promote thrombosis and brain injury in acute ischemic stroke
Xin Gao, Xinyi Zhao, Jiacheng Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11

Prolonged myelin deficits contribute to neuron loss and functional impairments after ischaemic stroke
Yong-Jie Cheng, Fei Wang, Jie Feng, et al.
Brain (2024) Vol. 147, Iss. 4, pp. 1294-1311
Closed Access | Times Cited: 10

Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3β-mediated oxidative stress and IRE1α/TRAF2/JNK pathway
Bingtian Xu, Jiangping Xu, Ningbo Cai, et al.
Free Radical Biology and Medicine (2020) Vol. 163, pp. 281-296
Closed Access | Times Cited: 65

MicroRNA: An Emerging Predictive, Diagnostic, Prognostic and Therapeutic Strategy in Ischaemic Stroke
Rais Reskiawan A. Kadir, Mansour Alwjwaj, Ulvi Bayraktutan
Cellular and Molecular Neurobiology (2020) Vol. 42, Iss. 5, pp. 1301-1319
Open Access | Times Cited: 51

Page 1 - Next Page

Scroll to top